Auro Laboratories has informed that a Meeting of the Board of Directors of the Company will be held on February 10, 2017, to consider and approve the Unaudited Financial Results for the quarter ended December 31, 2016. The ‘Trading Window’ under SEBI (Prohibition of Insider Trading) Regulations, 2015 will remain closed from January 31, 2017 to for all designated persons of the Company and their immediate relatives and shall be opened 48 hours after the information is made public.
The above information is a part of company’s filings submitted to BSE.